Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pacira Pharmaceuticals Inc (NASDAQ:PCRX)

47.30
BATS BZX Real-Time Price
As of 10:36am ET
 +0.40 / +0.85%
Today’s Change
29.95
Today|||52-Week Range
65.64
+46.44%
Year-to-Date
4 Biotech Stocks to Watch
Mar 22 / GuruFocus News - Paid Partner Content
Top Stocks That Are Already Crushing the Market in 2017
Mar 13 / MotleyFool.com - Paid Partner Content
Why Pacira Pharmaceuticals Stock Is Already Up 56% This Year
Mar 15 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close46.90
Today’s open46.40
Day’s range46.40 - 47.45
Volume1,723
Average volume (3 months)1,103,964
Market cap$1.8B
Dividend yield--
Data as of 10:36am ET, 03/27/2017

Growth & Valuation

Earnings growth (last year)-2,650.00%
Earnings growth (this year)-53.36%
Earnings growth (next 5 years)+120.00%
Revenue growth (last year)+10.99%
P/E ratioNM
Price/Sales4.35
Price/Book8.03

Competitors

 Today’s
change
Today’s
% change
TBPHTheravance Biopharma...-0.15-0.44%
CBMCambrex Corp+0.15+0.30%
GBTGlobal Blood Therape...+1.25+3.19%
SRPTSarepta Therapeutics...-0.04-0.13%
Data as of 10:39am ET, 03/27/2017

Financials

Next reporting dateMay 4, 2017
EPS forecast (this quarter)-$0.02
Annual revenue (last year)$276.4M
Annual profit (last year)-$37.9M
Net profit margin-13.73%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
David M. Stack
President
James S. Scibetta
Corporate headquarters
Parsippany, New Jersey

Forecasts


Search for Jobs